Page last updated: 2024-08-23

etoposide and vx680

etoposide has been researched along with vx680 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, XF; Li, J; Liu, Q; Luo, SK; Wan, XB; Wang, LH; Wang, XR; Xu, DR; Xu, J; Yan, M; Zeng, YX; Zheng, FM	1
Dreier, MR; Grabovich, AZ; Katusin, JD; Taylor, WR	1

Other Studies

2 other study(ies) available for etoposide and vx680

Article	Year
Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia. Blood, 2008, Mar-01, Volume: 111, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Apoptosis; Aurora Kinases; bcl-2-Associated X Protein; Bone Marrow Cells; Caspases; Cell Division; Cell Line, Tumor; Child; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Etoposide; Female; fms-Like Tyrosine Kinase 3; G2 Phase; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Piperazines; Protein Serine-Threonine Kinases	2008
Short and long-term tumor cell responses to Aurora kinase inhibitors. Experimental cell research, 2009, Apr-15, Volume: 315, Issue:7 Topics: Animals; Antineoplastic Agents, Phytogenic; Aurora Kinases; Benzamides; Cell Cycle; Cell Line, Tumor; DNA Damage; Enzyme Inhibitors; Etoposide; Histones; Humans; Piperazines; Protein Serine-Threonine Kinases; Quinazolines; Tumor Suppressor Protein p53	2009

Article

Year

Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia.

Blood, 2008, Mar-01, Volume: 111, Issue:5

Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Apoptosis; Aurora Kinases; bcl-2-Associated X Protein; Bone Marrow Cells; Caspases; Cell Division; Cell Line, Tumor; Child; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Etoposide; Female; fms-Like Tyrosine Kinase 3; G2 Phase; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Piperazines; Protein Serine-Threonine Kinases

2008

Short and long-term tumor cell responses to Aurora kinase inhibitors.

Experimental cell research, 2009, Apr-15, Volume: 315, Issue:7

Topics: Animals; Antineoplastic Agents, Phytogenic; Aurora Kinases; Benzamides; Cell Cycle; Cell Line, Tumor; DNA Damage; Enzyme Inhibitors; Etoposide; Histones; Humans; Piperazines; Protein Serine-Threonine Kinases; Quinazolines; Tumor Suppressor Protein p53

2009